Reply to BRCA2-associated pancreatic cancer and current screening guidelines

Affiliations

¹ Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
² Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Free article

Comment

Jennifer K Litton et al. Cancer. 2015.

Free article

. 2015 Sep 1;121(17):3047.

doi: 10.1002/cncr.29446. Epub 2015 May 27.

¹ Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
² Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

No abstract available

Comment on

BRCA2-associated pancreatic cancer and current screening guidelines.
Kasi PM, Pedersen KS, McWilliams RR. Kasi PM, et al. Cancer. 2015 Sep 1;121(17):3046. doi: 10.1002/cncr.29447. Epub 2015 May 27. Cancer. 2015. PMID: 26018189 No abstract available.
Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK and Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121:269-275.
[No authors listed] [No authors listed] Cancer. 2015 Jul 15;121(14):2474-5. doi: 10.1002/cncr.29357. Epub 2015 Apr 17. Cancer. 2015. PMID: 26132389 No abstract available.